How do I choose between different sterile fill-finish CDMO providers for vials, syringes, and cartridges?

Choosing a sterile fill-finish CDMO is mostly about matching the provider’s technical fit, regulatory maturity, supply reliability, and commercial flexibility to your product and launch plan. For vials, syringes, and cartridges, the “best” provider can differ a lot depending on the container, drug type, and stage of development.

Here’s a practical way to evaluate them.

1) Start with your product requirements

Before comparing CDMOs, define:

• Drug modality: small molecule, biologic, mAb, peptide, vaccine, cell/gene-adjacent, etc.
• Formulation: liquid or lyophilized, pH sensitivity, viscosity, oxygen sensitivity
• Dose volume and fill range
• Container type: vial, prefilled syringe (PFS), cartridge
• Delivery device needs: autoinjector, pen, pump, needle safety device
• Stability constraints: cold chain, frozen, light sensitivity
• Sterility assurance needs: aseptic processing vs terminal sterilization
• Batch size and scale: clinical, commercial, or both
• Timeline: tech transfer, first engineering run, validation, launch
• Geography: where you want supply, labeling, and regulatory filing support

This narrows the field quickly. A CDMO that is excellent for vials may not be ideal for high-value prefilled syringes or cartridge-based drug-device combinations.

2) Evaluate platform fit by container type

Vials

Look for:

• Strong aseptic filling capability
• Lyophilization expertise if needed
• Stoppering and crimping quality
• Good particulate and container-closure integrity control
• Ability to handle higher batch flexibility and multiple fill volumes

Vials are usually the most flexible and lowest-risk format operationally.

Prefilled syringes

Look for:

• Experience with siliconization, plunger insertion, and low-particulate processes
• Ability to manage break-loose and glide forces
• Strong extractables/leachables expertise
• Compatibility with glass and polymer syringes
• Device assembly and inspection capabilities

PFS is often more sensitive to container compatibility and device performance.

Cartridges

Look for:

• Experience with cartridge filling and nested formats
• High accuracy filling for small volumes
• Strong control of headspace, oxygen, and bubble management
• Compatibility with pen injectors and connected devices
• Inspection and integration with downstream assembly partners

Cartridges can be especially demanding if used in combination products or pens.

3) Check regulatory and quality maturity

This is non-negotiable.

Ask about:

• GMP inspection history and warning letters
• FDA, EMA, MHRA, PMDA, or other relevant inspection experience
• Aseptic process simulation / media fill success history
• Sterility assurance, environmental monitoring, and contamination control strategy
• Deviations, CAPA system, and batch release performance
• Audit readiness and data integrity practices

A provider with strong quality systems may save you far more than a cheaper quote can offset.

4) Assess technical and process capabilities

Key questions:

• Can they handle your molecule’s sensitivity to shear, temperature, light, and oxygen?
• Do they have the right filling line configuration for your container?
• Can they work with your selected closure system and supplier?
• Do they support nitrogen overlay, vacuum stoppering, cold fill, or lyophilization?
• Do they have in-process controls that match your CQAs?
• How do they manage scale-up from clinical to commercial?

For difficult molecules, ask for case studies or anonymized examples of similar products.

5) Understand container supply and component strategy

A common hidden risk is not the fill-finish itself, but component availability.

Evaluate:

• Ability to source or qualify vials, stoppers, syringe barrels, plungers, cartridges, and nest/tub formats
• Dual sourcing strategy for critical components
• Lead times and inventory management
• Compatibility testing with your selected container-closure system
• Support for supplier qualification and change control

If the CDMO depends on a single supplier for a critical component, that can become a bottleneck.

6) Review inspection and packaging capabilities

For sterile injectable products, inspection is critical.

Look for:

• 100% visual inspection and/or automated inspection systems
• Ability to detect particulates, cosmetic defects, fill volume issues, and defects in closure
• Leak testing and container-closure integrity testing
• Secondary packaging and serialization, if needed
• Cold-chain packaging and logistics support

The best fill-finish provider should reduce not only contamination risk but also downstream rejection risk.

7) Evaluate tech transfer and project management strength

A technically capable CDMO can still fail if tech transfer is weak.

Ask:

• Who leads tech transfer and how experienced is the team?
• What is their standard timeline from kickoff to PPQ/validation?
• How many internal handoffs are involved?
• How do they manage documentation, change control, and risk assessments?
• What does governance look like: weekly calls, escalation path, dedicated PM?

Clear project management often distinguishes a smooth launch from a costly delay.

8) Compare capacity, scheduling, and responsiveness

A CDMO may be perfect on paper but unavailable in practice.

Assess:

• Available line capacity and dedicated versus shared lines
• Ability to reserve slots for engineering, clinical, and commercial batches
• Typical lead times for campaign scheduling
• Flexibility for expedited projects
• Business continuity and backup plans for equipment downtime

If your launch is time-sensitive, scheduling reliability may outweigh minor cost differences.

9) Consider commercial terms and total cost of ownership

Don’t just compare per-vial or per-syringe price.

Include:

• Tech transfer fees
• Validation and media fill costs
• Component sourcing costs
• Analytical testing charges
• Stability and retain sample costs
• Cold-chain packaging and freight
• Minimum batch commitments
• Change order and deviation-related costs

The lowest quote is often not the lowest total cost.

10) Gauge their fit for your product lifecycle

Different CDMOs are better for different stages:

• Early clinical: speed, flexibility, small batches, formulation iteration
• Late clinical: scale-up, comparability, validation readiness
• Commercial: capacity, supply continuity, regulatory robustness, cost control

If you expect format changes, select a provider with a path from development to commercial supply in the same network, or at least with proven transfer capability.

11) Ask for a formal due diligence package

A good RFP should request:

• Facility summary and line list
• Regulatory inspection history
• Quality metrics
• Typical batch sizes and yields
• Container formats supported
• Lyophilization capability, if relevant
• Inspection and packaging services
• Supply chain and component sourcing model
• Representative project timelines
• References or case studies
• Business continuity and disaster recovery plans

12) Red flags

Be cautious if they:

• Overpromise timelines without clear capacity
• Have weak or outdated inspection history
• Cannot explain their contamination control strategy clearly
• Lack experience with your container format
• Have limited component sourcing support
• Resist sharing deviation, OOS, or batch failure management practices
• Treat tech transfer as a generic checklist rather than product-specific work

Practical selection approach

A simple scoring matrix helps. Weight categories such as:

• Quality/regulatory: 25%
• Technical fit: 25%
• Capacity/timeline: 20%
• Supply chain robustness: 10%
• Commercial terms: 10%
• Project management/communication: 10%

Then score each CDMO separately for vials, syringes, and cartridges, because the best provider may vary by format.

Bottom line

Choose the CDMO that best matches:

1. Your container format and product sensitivity
2. Strong aseptic and regulatory performance
3. Reliable component supply
4. Proven tech transfer and capacity
5. Total cost and long-term scalability

If you want, I can also give you:

• a CDMO comparison scorecard template
• a vendor RFP checklist
• or a container-specific decision guide for vials vs syringes vs cartridges.